GlassScriptPhysician profile
Renzo Laynes
NPI 1710516158
$11,088.14
in general payments reported to CMS, 2019-2025
7 companies · $5,639 in 2025
The $5,639 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.02 · 2022: $2,400 · 2023: $893 · 2024: $2,141 · 2025: $5,639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,112 · Grant: $3,000 · Travel and Lodging: $2,527 · Education: $34.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,111.52 |
| Grant | $3,000.00 |
| Travel and Lodging | $2,526.74 |
| Education | $34.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,216.27 | 2021-2025 | Infuse Bone Graft, Midas Rex, Cd Horizon Spinal System |
| Orthofix Medical, INC. | $3,166.18 | 2025 | Mariner Deformity, 7d Surgical System, Mariner Mis |
| Gemini Mountain Medical, LLC | $2,441.72 | 2022-2025 | |
| Stryker Corporation | $1,660.10 | 2023-2025 | Axsos, Pangea, T2 |
| Depuy Synthes Sales INC. | $258.77 | 2024-2025 | Motoband, Motoband Cp, Va-Lcp |
| Si-Bone, INC. | $189.70 | 2025 | |
| Cerapedics INC. | $155.40 | 2023 | I-Factor Peptide Enhanced Bone Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renzo Laynes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.